Advanced search
Publication Cover
Current Medical Research and Opinion Volume 19, 2003 - Issue 4
Submit an article Journal homepage
31
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain:results of phase 2 of theVICOXX study

Dr Luis R. Arboleya Rheumatology Section, Hospital de Cabueñes, Gijón, SpainCorrespondence[email protected]
,
Enrique de la Figuera Centro de Salud Delicias Sur, INSALUD, Zaragoza, Spain
,
María Soledad García Chiltern International S.A., Spain
&
Belén Aragón Chiltern International S.A., Spain
Pages 288-297 | Accepted 07 May 2003, Published online: 22 Sep 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

M. Corral, N. Ferko, S. Hollmann, A. Hogan, N. Jamous, J. Batiller & J. Shen. (2016) Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: results from four randomized controlled trials. Current Medical Research and Opinion 32:2, pages 367-375.
Read now
Luis R. Arboleya, Enrique de la Figuera, María Soledad García & Belén Aragón. (2003) Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs. Current Medical Research and Opinion 19:4, pages 278-287.
Read now

Articles from other publishers (4)

Tilo Grosser. (2023) Variability in the Response to Cyclooxygenase Inhibitors: Toward the Individualization of Nonsteroidal Anti-Inflammatory Drug Therapy. Journal of Investigative Medicine 57:6, pages 709-716.
Crossref
E.M. Lima Rodríguez & J.M. Calvo Romero. (2005) Toxicidad gastrointestinal del rofecoxib. Atención Primaria 35:2, pages 110-111.
Crossref
JV Bagán, K Thongprasom & C Scully. (2004) Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. Oral Diseases 10:6, pages 401-403.
Crossref
Helmut Schmidt, Barry G Woodcock & Gerd Geisslinger. (2004) Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis. Drug Safety 27:3, pages 185-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.